Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 37

Results For "Mila"

660 News Found

Marksans Pharma completes acquisition of manufacturing site from Tevapharm India
News | April 20, 2023

Marksans Pharma completes acquisition of manufacturing site from Tevapharm India

Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards


Shilpa Medicare receives USFDA approval for Psoriatic Arthritis Drug
Drug Approval | April 11, 2023

Shilpa Medicare receives USFDA approval for Psoriatic Arthritis Drug

Apremilast Tablets, 10 mg, 20 mg, and 30 mg is a generic equivalent of reference listed drug (RLD) OTEZLA of Celgene.


India showcases achievements in health sector in run up to 2nd G20 Health Working Group Meeting
Policy | April 05, 2023

India showcases achievements in health sector in run up to 2nd G20 Health Working Group Meeting

Successes under Ayushman Bharat Digital Health Mission and Pradhan Mantri National Dialysis Programme highlighted


Govt. reviews public health preparedness for management of COVID-19
Public Health | March 28, 2023

Govt. reviews public health preparedness for management of COVID-19

States advised to undertake mock drills to ensure operational readiness of Hospital Infrastructure including Oxygen Cylinders, PSA plants, ventilators and human resources


Drug coated balloons is an alternative to stents in younger patients: Experts
News | March 18, 2023

Drug coated balloons is an alternative to stents in younger patients: Experts

This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective


ICMR approves Krivida Trivus to detect Influenza, SARS CoV2, and RSV
Public Health | March 17, 2023

ICMR approves Krivida Trivus to detect Influenza, SARS CoV2, and RSV

KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.


2654 compounds screened for different activities for GPCR profiling: Dr Jitendra Singh
Policy | March 16, 2023

2654 compounds screened for different activities for GPCR profiling: Dr Jitendra Singh

MoES have identified a potent Anti-cancer molecule named GS/IICT5/6


Briefs: Lupin and Alembic
News | March 14, 2023

Briefs: Lupin and Alembic

Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.


Jan Aushadhi Train flagged off by Mandaviya and Vaishnaw in New Delhi
News | March 04, 2023

Jan Aushadhi Train flagged off by Mandaviya and Vaishnaw in New Delhi

Jan Aushadhi highlights achievements of women of the country at 34 locations by felicitating all women stakeholders under the scheme


Agilent announces cell analysis workflow automation for immuno-oncology, virology, and vaccine development markets
Digitisation | February 27, 2023

Agilent announces cell analysis workflow automation for immuno-oncology, virology, and vaccine development markets

New workflow integrates the xCELLigence RTCA HT with the BioTek BioSpa 8 Automated Incubator